Xeljanz

Biora, with spin on Xeljanz nearing the clinic, posts data on its targeted gut drug delivery device
Fierce Pharma
Tue, 07/12/22 - 10:44 am
Biora
Xeljanz
drug delivery
PGN-600
Progenity
Pfizer Lining Up New UC Drug, Former Employees Launch Counter Suit
BioSpace
Wed, 03/23/22 - 10:56 pm
Pfizer
ulcerative colitis
Xeljanz
Pfizer Snagged Another Approval for This Immunology Drug
Motley Fool
Mon, 01/3/22 - 10:48 am
Pfizer
ankylosing spondylitis
Xeljanz
What to Make of the FDA's Latest Warning to AbbVie and Pfizer
Motley Fool
Sat, 12/18/21 - 10:56 pm
FDA
AbbVie
Pfizer
Rinvoq
Xeljanz
JAK inhibitors
Amid safety concerns, FDA grants two new JAK approvals — but with added warnings and a key label change
Endpoints
Wed, 12/15/21 - 10:52 am
Pfizer
AbbVie
Xeljanz
Rinvoq
FDA
JAK inhibitors
Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds
Fierce Pharma
Wed, 11/10/21 - 09:39 pm
Eli Lilly
olumiant
JAK inhibitors
Pfizer
Xeljanz
Pfizer gets first approval, in UK, for Xeljanz follow-up Cibinqo
Pharmaforum
Thu, 09/9/21 - 11:13 pm
Pfizer
Cibinqo
atopic dermatitis
eczema
UK
Xeljanz
Pfizer’s arthritis drug Xeljanz shows lifesaving benefits in hospitalized COVID-19 patients
Fierce Pharma
Thu, 06/17/21 - 11:00 pm
Pfizer
Xeljanz
COVID-19
AbbVie's Rinvoq rollout on track despite JAK safety concerns, but uncertainty remains: analyst
Fierce Pharma
Thu, 04/22/21 - 11:42 pm
AbbVie
Rinvoq
Xeljanz
FDA
rheumatoid arthritis
Series of JAK inhibitor delays may signal an upcoming FDA adcomm
Endpoints
Thu, 04/8/21 - 11:10 am
FDA
JAK inhibitors
AbbVie
Rinvoq
Pfizer
Xeljanz
Eli Lilly
olumiant
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
Motley Fool
Thu, 02/11/21 - 10:56 am
Pfizer
M&A
BioNTech
Xeljanz
FDA weighs tighter restrictions for Pfizer's Xeljanz on the heels of safety red flags
Fierce Pharma
Sat, 02/6/21 - 10:38 pm
Pfizer
Xeljanz
FDA
FDA holds back from action over Xeljanz safety study FDA holds back from action over Xeljanz safety study
Pharmaforum
Fri, 02/5/21 - 10:40 am
Pfizer
FDA
Xeljanz
rheumatoid arthritis
Will Pfizer's Latest Bad News Wipe Out a Big Chunk of Its COVID Vaccine Profits?
Motley Fool
Tue, 02/2/21 - 10:34 am
Pfizer
vaccines
COVID-19
Xeljanz
Safety finding weighs on Pfizer's inflammation drug, and could spell trouble for others
BioPharma Dive
Wed, 01/27/21 - 07:59 pm
Xeljanz
Pfizer
Pfizer gets FDA nod for Xeljanz to treat juvenile idiopathic arthritis
Pharmaceutical Business Review
Tue, 09/29/20 - 11:56 am
Pfizer
Xeljanz
FDA
polyarticular juvenile idiopathic arthritis
Pfizer may have a lot going on in immunology, but all its drugs could be beaten by rivals: analyst
Fierce Pharma
Thu, 07/9/20 - 10:21 pm
Pfizer
immunology
abrocitinib
Xeljanz
PF-06651600
Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move
Fierce Pharma
Sat, 11/16/19 - 10:27 pm
Europe
EMA
ulcerative colitis
Pfizer
Xeljanz
ICER pulls report blasting ‘marginal’ RA drugs, citing need to rethink its approach
Fierce Pharma
Wed, 10/2/19 - 11:53 am
ICER
JAK inhibitors
rheumatoid arthritis
AbbVie
Rinvoq
Pfizer
Xeljanz
Incyte
olumiant
Following EMA, FDA restricts use of high-dose Xeljanz, warning of added risks for the blockbuster JAK
Endpoints
Fri, 07/26/19 - 11:14 am
FDA
Pfizer
Xeljanz
warning
EMA

Pages